CP and glioblastoma: Glioblastoma tumour growth was significantly decelerated with CP treatment, with immunohistological analysis showing extensive DNA damage, NOX3 expression (indicating endogenous H2O2 production), and caspase 3 activation, which implicate JNK and p38 activity, but tumour growth still persisted [152].